These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 7301606)
1. [Diprophos in the treatment of asthma. Preliminary observations]. Szczeklik A; Adamek-Guzik T; Turowska T Pneumonol Pol; 1981; 49(8-9):641-4. PubMed ID: 7301606 [No Abstract] [Full Text] [Related]
2. [Evaluation of Diprophos in the treatment of asthma]. Jacyna K; Koczorowski T Pneumonol Pol; 1981; 49(8-9):637-9. PubMed ID: 7301605 [No Abstract] [Full Text] [Related]
3. [Injectable long-acting corticoid therapy (betamethasone dipropionate) in bronchial asthma]. Seropian E Med Interna (Bucur); 1974 Apr; 26(4):487-96. PubMed ID: 4839355 [No Abstract] [Full Text] [Related]
4. [Adrenal cortex function in bronchial asthma or asthmatic syndromes treated with betamethasone dépôt (Diprophos)]. Piotrowska B; Droszcz W; Małunowicz E; Lech B Pneumonol Pol; 1981; 49(8-9):609-13. PubMed ID: 7301602 [No Abstract] [Full Text] [Related]
6. [Practical experiences of long-term therapy with a new depot-glucocorticosteroid. (Depot-betamethasone-celestone-chronodose)]. Budde C; Lehner H Praxis; 1968 Oct; 57(39):1344-7. PubMed ID: 5756754 [No Abstract] [Full Text] [Related]
7. [Some clinical observations on the use of betamethasone intravenously in lung diseases]. Belloni PA Minerva Med; 1967 May; 58(22):933-40. PubMed ID: 6025651 [No Abstract] [Full Text] [Related]
8. [Clinical studies on the effect of Diprophos in bronchial asthma]. Krasnowska M; Suchnicka R; Małolepszy J; Jankowska R; Nittner M Pneumonol Pol; 1984 Jan; 52(1):27-31. PubMed ID: 6369266 [No Abstract] [Full Text] [Related]
9. Elimination of severe height growth suppression caused by treatment with betamethasone after switching to ACTH-depot in chronic bronchial asthma. Moulaert AJ; Van Gemund JJ Helv Paediatr Acta; 1972 Apr; 21(1):55-62. PubMed ID: 4336638 [No Abstract] [Full Text] [Related]
10. Use of betamethasone in intractable asthma. Abram LE; Fine AJ West Med Med J West; 1967 Feb; 8(2):61-2. PubMed ID: 6072165 [No Abstract] [Full Text] [Related]
11. [Infusion treatment of status asthmaticus. Hydrocortisone or betamethasone?]. Eriksson NE; Formgren H; Larsson S Lakartidningen; 1972 Oct; 69():Suppl 3:44-9. PubMed ID: 4643063 [No Abstract] [Full Text] [Related]
12. Treatment of seasonal allergic rhinitis with long-acting steroid injections. A comparison of four preparations. Chervinsky P Ann Allergy; 1968 Apr; 26(4):190-3. PubMed ID: 5644715 [No Abstract] [Full Text] [Related]
13. A synthetic polypeptide--beta 1-24 corticotropin--in the depot form. II. Clinical efficacy of intermittent therapy in asthmatic patients. Benos SA; Koutsoukos A; Sotirakis I; Pavlatos FC Acta Allergol; 1969 Sep; 24(3):178-86. PubMed ID: 4314190 [No Abstract] [Full Text] [Related]
14. [The clinical efficacy and characteristics of the effect of prolonged-action theophyllines on the external respiratory function and hemodynamics of bronchial asthma patients]. Kakhnovskiĭ IM; Solomatin AS; Vdovina TI Ter Arkh; 1995; 67(1):48-51. PubMed ID: 7709358 [No Abstract] [Full Text] [Related]
16. [Apropos of the clinical use of the long-acting betamethasone preparation (celestone chronodose) in ophtalmology]. Faggioni R Schweiz Med Wochenschr; 1968 Jun; 98(26):976-9. PubMed ID: 5304126 [No Abstract] [Full Text] [Related]